Clinical Trial End Points in Severe COVID-19

Aakash Desai; Amit Kulkarni; S. Vincent Rajkumar; Bishal Gyawali

doi:10.1016/j.mayocp.2020.05.025

Clinical Trial End Points in Severe COVID-19

Aakash Desai, Amit Kulkarni, S. Vincent Rajkumar, Bishal Gyawali

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Short survey › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1578-1580
Number of pages	3
Journal	Mayo Clinic Proceedings
Volume	95
Issue number	8
DOIs	https://doi.org/10.1016/j.mayocp.2020.05.025
State	Published - Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.mayocp.2020.05.025

OpenUrl availability

Full text

Cite this

@article{aa371be88866400cba97786c4bf3a7af,

title = "Clinical Trial End Points in Severe COVID-19",

author = "Aakash Desai and Amit Kulkarni and Rajkumar, {S. Vincent} and Bishal Gyawali",

year = "2020",

month = aug,

doi = "10.1016/j.mayocp.2020.05.025",

language = "English (US)",

volume = "95",

pages = "1578--1580",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "8",

}

TY - JOUR

T1 - Clinical Trial End Points in Severe COVID-19

AU - Desai, Aakash

AU - Kulkarni, Amit

AU - Rajkumar, S. Vincent

AU - Gyawali, Bishal

PY - 2020/8

Y1 - 2020/8

UR - http://www.scopus.com/inward/record.url?scp=85088843263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088843263&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2020.05.025

DO - 10.1016/j.mayocp.2020.05.025

M3 - Short survey

C2 - 32753131

AN - SCOPUS:85088843263

SN - 0025-6196

VL - 95

SP - 1578

EP - 1580

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 8

ER -

Clinical Trial End Points in Severe COVID-19

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this